[2] As a result of her research in molecular biology, she was elected a Fellow of the American Society for Clinical Investigation in 2000.
[3] Following her promotion to Full professor with tenure in 2002,[4] Cho's laboratory developed a mouse model to research ovarian endometrioid adenocarcinoma.
[6] Following this, she was elected a member of the National Academy of Medicine for both her diagnostic expertise and laboratory research in gynecological cancer.
[7] In 2017, her research team used genetically modified mice to mimic tumors that closely resembled human high-grade serous carcinomas.
[6] In January 2019, Cho received a five-year R01 grant from the National Institutes of Health to continue her work in ovarian cancer research.